Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2021 | WCG Clinical : GIC-backed clinical trial firm WCG withdraws U.S. IPO plans | RE |
2021 | WCG Clinical : GIC-backed clinical trial firm WCG withdraws IPO plans | RE |
Sales 2019 | 413M 34.42B | Sales 2020 | 463M 38.64B | Capitalization | 6.07B 506B |
---|---|---|---|---|---|
Net income 2019 | 18M 1.5B | Net income 2020 | -95M -7.92B | EV / Sales 2019 * | - |
Net cash position 2019 * | - 0 | Net cash position 2020 * | - 0 | EV / Sales 2020 * | - |
P/E ratio 2019 * |
-
| P/E ratio 2020 * |
-
| Employees | - |
Yield 2019 * |
-
| Yield 2020 * |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Srivastava Sam
CEO | Chief Executive Officer | - | - |
Nicholas Slack
PSD | President | 41 | 01/12/01 |
Ian Neilson
CTO | Chief Tech/Sci/R&D Officer | - | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Baumer
BRD | Director/Board Member | 56 | 01/19/01 |
Eugene Gorbach
BRD | Director/Board Member | 47 | 01/12/01 |
Director/Board Member | 66 | 01/12/01 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 6.07B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- WCGC Stock